NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/25/2025
Back to search
Official data from USPTO
RING
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
02/25/2025
Trademark type
Word
Nice classes
5
Filing date
08/30/2023
Registration date
02/25/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/25/2025
Last transaction
02/25/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/16/2024
First use in commerce
09/16/2024
Drawing code
4
Owner type
03
Owner location
Cambridge, MA, US
Examiner
SABAGH, LAILA TAREK
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Ring Therapeutics, Inc.
Representatives
Christina M. Licursi WOLF, GREENFIELD & SACKS, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of rare genetic disorderscardiovascular diseasesrespiratory diseasesinfectious diseasesretinal diseasesmetabolic disordershormonal deficienciesendocrine diseaseseye diseases and disordersintestinal diseasesautoimmune diseasesautoinflammatory diseasesinflammatory disordersmusculoskeletal diseasesneurological disordershematologic conditionscutaneous conditionsneurodegenerative diseasescongenital disorderskidney and urinary diseasesreproductive diseasesmitochondrial diseaseslung disordersimmune system diseasesmouth diseasesdigestive diseases; pharmaceutical preparations for use in the preventiondiagnosis and treatment of diseaserare genetic disorderscardiovascular diseasesrespiratory diseasesinfectious diseasesretinal diseasesmetabolic disordershormonal deficienciesendocrine diseaseseye diseases and disordersintestinal diseasesautoimmune diseasesautoinflammatory diseasesinflammatory disordersmusculoskeletal diseasesneurological disordershematologic conditionscutaneous conditionsneurodegenerative diseasescongenital disorderskidney and urinary diseasesreproductive diseasesmitochondrial diseaseslung disordersimmune system diseasesmouth diseasesdigestive diseases; pharmaceutical preparations for use in gene therapy
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/25/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/31/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/31/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/04/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/04/2025
IUAF
USE AMENDMENT FILED
10/17/2024
EISU
TEAS STATEMENT OF USE RECEIVED
10/17/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/27/2024
EX1G
SOU EXTENSION 1 GRANTED
08/27/2024
EXT1
SOU EXTENSION 1 FILED
08/27/2024
EEXT
SOU TEAS EXTENSION RECEIVED
08/27/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/27/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/02/2024
PUBO
PUBLISHED FOR OPPOSITION
01/02/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/26/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/26/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/26/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/13/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/29/2023
DOCK
ASSIGNED TO EXAMINER
11/28/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/27/2023
NWAP
NEW APPLICATION ENTERED
09/02/2023
Continuous trademark protection
Get notified about every new filing that threatens RING or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.